JAZZ News and Press, Jazz Pharmaceuticals plc From 03/24/21

There has been a surge of mergers and acquisitions activity in the cannabis industry of late. Aphria (NASDAQ: APHA) and Tilray (NASDAQ: TLRY) are linking up in one of the sector's highest-profile mergers, and other industries are getting in on the action. Jazz Pharmaceutic...

Jazz Pharmaceuticals Announces Participation at the 10th Annual J.P. Morgan Napa Valley Forum PR Newswire DUBLIN , March 22, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will webcast its corporate presentation...

Jazz Pharmaceuticals and Hypersomnia Foundation Launch Campaign to Increase Understanding and Awareness of Idiopathic Hypersomnia Initiative aims to generate awareness about idiopathic hypersomnia and encourage those who may be struggling with the sleep disorder to have effectiv...

Are you looking for some ridiculously cheap stocks to buy? Despite the Dow Jones Industrial Average hanging out around all-time highs, there are still some good deals out there. It isn't always easy finding them, especially since the coronavirus pandemic has crippled many businesses, ma...

Shares of GW Pharmaceuticals (NASDAQ: GWPH) rose 40.5% in February, according to data provided by S&P Global Market Intelligence . The bulk of the move came on Feb. 3 when Jazz Pharmaceuticals (NASDAQ: JAZZ) announced it would be purchasing GW for $7.2 billion, or th...

Stocks are correcting after getting over-extended. Market leadership is shifting by sector and industry. Strong stocks can bounce back when the sell-off subsides. For further details see: Top Stocks To Buy On The Sell-Off

GW Pharmaceuticals (GWPH) announced that the European Medicines Agency has issued a positive opinion on its Type II variation application for EPIDYOLEX® (cannabidiol) as an adjunctive treatment of seizures associated with Tuberous Sclerosis Complex.The decision by the EMA’s Commit...

The biggest news for Jazz Pharmaceuticals (NASDAQ: JAZZ) in recent months was the company's announcement earlier this month that it plans to acquire GW Pharmaceuticals in a $7.6 billion deal. Investors initially weren't very thrilled with the acquisition, but later seemed to...

Image source: The Motley Fool. Jazz Pharmaceuticals PLC (NASDAQ: JAZZ) Q4 2020 Earnings Call Feb 23, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Jazz Pharmaceuticals PLC (JAZZ) Q4 2020 Earnings Call Transcript ...

Jazz Pharmaceuticals plc (JAZZ) Q4 2020 Earnings Conference Call February 23, 2021 04:30 PM ET Company Participants Andrea Flynn - Head of Investor Relations Bruce Cozadd - Chief Executive Officer Renée Galá - Chief Financial Officer Dan Swisher - President Rob Iannone - Executive V...